High-purity Tesamorelin 10mg is available for qualified laboratory research institutions evaluating growth hormone secretagogues. PX1 Research provides fully characterized, USA-manufactured research peptides supported by lot-specific analytical verification and rapid logistics.
High-purity Tesamorelin 10mg is available for qualified laboratory research institutions evaluating growth hormone secretagogues. PX1 Research provides fully characterized, USA-manufactured research peptides supported by lot-specific analytical verification and rapid logistics.
Sourcing Tesamorelin 10mg for in vitro assays or preclinical animal models requires strict verification of chemical purity, sequence integrity, and bioburden controls. Qualified research institutions can procure high-purity Tesamorelin 10mg directly from PX1 Research. Every lot undergoes rigorous testing, including reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS), to confirm a minimum purity threshold of 98%.
Tesamorelin is a synthetic 44-amino acid growth hormone-releasing hormone (GHRH) peptide derivative stabilized by a trans-3-hexenoic acid group at its N-terminus. This structural adaptation enhances enzymatic resistance compared to native hypothalamic GHRH. When evaluating suppliers for all research peptides, laboratories must ensure every batch includes a traceable Certificate of Analysis (COA) detailing identity, purity, and endotoxin metrics to preserve experimental reproducibility.
Tesamorelin represents a modified sequence of endogenous human GHRH (1-44). The native hormone is rapidly degraded in biological systems by dipeptidyl peptidase-IV (DPP-IV), which cleaves the N-terminal Ala1-Tyr2 dipeptide and significantly reduces biological half-life. To overcome this rapid cleavage in controlled preclinical models, Tesamorelin incorporates a hexenoyl moiety attached to the N-terminal tyrosine residue.
This N-terminal lipophilic modification creates steric hindrance against DPP-IV enzymatic cleavage without compromising receptor binding affinity. Preclinical studies suggest that this structural alteration increases metabolic stability while maintaining selective agonism at the pituitary GHRH receptor. Investigators exploring GHRH analogs utilize Tesamorelin specifically to examine sustained receptor stimulation profiles relative to unmodified native peptides.
At the cellular level, Tesamorelin binds specifically to the GHRH receptor (GHRHR), a class B G-protein coupled receptor expressed primarily on pituitary somatotrophs. Ligand engagement triggers conformational changes that activate adenylate cyclase via Gs protein coupling. This leads to an intracellular rise in cyclic adenosine monophosphate (cAMP) and activation of protein kinase A (PKA).
In vitro data indicate that PKA phosphorylation subsequently opens voltage-gated L-type calcium channels, driving calcium influx that stimulates the exocytosis of pre-stored growth hormone (GH) secretory granules. Concurrently, the cAMP-PKA cascade activates CREB transcript factors, promoting GH gene transcription. Preclinical models demonstrate that this physiological cascade preserves natural pulsatile GH secretion patterns rather than inducing continuous, non-physiological GH elevation.
Elevated somatotroph GH secretion resulting from GHRHR agonism leads to increased hepatic synthesis and systemic secretion of insulin-like growth factor 1 (IGF-1). In rodent and non-human primate research models, the GHRH/GH/IGF-1 axis serves as a central regulator of cellular proliferation, protein translation, and lipid turnover. Research focused on IGF-1 signaling research frequently utilizes Tesamorelin to examine upstream endocrine modulation.
Preclinical lipid research reveals that Tesamorelin-mediated GH elevation enhances lipolysis in adipose tissue by upregulating hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL). Animal models evaluating visceral adiposity show significant reductions in ectopic fat accumulation, particularly within hepatic and retroperitoneal depots. These metabolic responses make Tesamorelin a prominent candidate in studies investigating hepatic lipid accumulation and metabolic dysregulation.
When designing protocols for secretagogue evaluation, researchers often compare Tesamorelin against other growth hormone secretagogues. Unmodified Sermorelin, representing the truncated 1-29 fragment of GHRH, exhibits a much shorter biological half-life due to rapid DPP-IV cleavage, requiring higher dosing frequency in animal models. Conversely, CJC-1295 NO DAC offers modified enzymatic stability but lacks the specific hexenoyl acyl addition that defines Tesamorelin's lipophilic interaction profile.
Furthermore, while GHRH receptor agonists like Tesamorelin act via the classical cAMP/PKA pathway, ghrelin receptor agonists such as Ipamorelin target the growth hormone secretagogue receptor (GHSR-1a) to induce GH release via intracellular calcium mobilization. Comparing these compounds allows research teams to isolate distinct signaling cascades within the pituitary secretagogue network. Comprehensive comparative data and reference profiles can be reviewed in the PX1 Research hub.
Ensuring experimental repeatability requires research compounds that meet strict analytical parameters. When laboratories order Tesamorelin 10mg, purity verification must extend beyond basic gravimetric measures. PX1 Research subjects every synthesis batch to rigorous double-verification testing conducted by independent ISO 17025 accredited laboratories.
Primary purity testing utilizes RP-HPLC with ultraviolet detection at 214 nm and 280 nm to identify and quantify potential peptide impurities, sequence truncations, or deletion sequences. Electrospray ionization mass spectrometry (ESI-MS) confirms molecular weight down to single Daltons (exact mass matching the theoretical formula C221H366N72O67S). Additionally, bacterial endotoxin testing via Chromogenic Reagent Kinetic LAL assay guarantees endotoxin levels remain strictly below <0.01 EU/μg to prevent non-specific inflammatory responses in cellular assays.
Tesamorelin 10mg is supplied as a lyophilized white powder under vacuum seal. For laboratory reconstitutions, research personnel should utilize sterile, preservative-containing solvents such as bacteriostatic water (0.9% benzyl alcohol) or sterile normal saline depending on the experimental application.
To reconstitute a 10mg vial to a standardized working concentration of 5 mg/mL, gently introduce 2.0 mL of sterile diluent along the glass wall of the vial. Avoid direct high-velocity stream impact onto the lyophilized cake to prevent mechanical shear stress and peptide denaturation. Swirl gently in a circular motion until fully dissolved; never vortex lyophilized peptide solutions. Reconstituted solutions should be clear and colorless, free from visible particulates or turbidity.
Lyophilized Tesamorelin 10mg demonstrates excellent long-term chemical stability when stored under controlled atmospheric conditions. Upon receipt, sealed lyophilized vials should be stored in desiccated conditions at -20°C for short-to-medium term storage, or -80°C for extended research repository storage. Under these conditions, the peptide maintains sequence stability for up to 24 months.
Once reconstituted, aqueous peptide solutions are susceptible to hydrolysis and aggregation. Reconstituted Tesamorelin should be kept refrigerated at 2°C to 8°C and utilized within 28 days when reconstituted with bacteriostatic solvents. Avoid repeated freeze-thaw cycles of liquid aliquots, as phase transitions induce structural aggregation and loss of biological activity in vitro.
PX1 Research operates dedicated, cGMP-compliant manufacturing and distribution facilities located in California and Arizona. This dual-hub US infrastructure ensures rapid, temperature-controlled fulfillment for time-sensitive academic, biotechnology, and institutional research projects. Orders placed Monday through Friday before 3:00 PM PST ship the same day.
For large-scale animal studies, high-throughput screening platforms, or ongoing longitudinal projects, laboratories can access volume pricing and batch reservation through our specialized wholesale lab accounts. Direct batch allocation ensures consistent lot tracking and uniform analytical profiles across long-term investigative studies.
What is the certified analytical purity of PX1 Research Tesamorelin 10mg?
Every lot of Tesamorelin 10mg distributed by PX1 Research is verified via RP-HPLC and ESI-MS to achieve a minimum of 98% purity, with complete lot-specific Certificates of Analysis available for download.
How is Tesamorelin 10mg tested for bacterial endotoxins?
Endotoxin levels are quantified using a kinetic chromogenic Limulus Amebocyte Lysate (LAL) assay performed by an independent ISO 17025 accredited laboratory. All lots must demonstrate endotoxin counts below <0.01 EU/μg.
What solvent is recommended for reconstituting Tesamorelin 10mg for laboratory use?
For multi-dose laboratory experiments, sterile bacteriostatic water (0.9% benzyl alcohol) is recommended to maintain stability and prevent microbial growth. For sensitive cell culture assays, sterile non-preserved 0.9% sodium chloride or phosphate-buffered saline (PBS) should be used.
What structural modification distinguishes Tesamorelin from native GHRH?
Tesamorelin features a trans-3-hexenoic acid moiety attached to the N-terminal Tyr1 residue of the GHRH (1-44) sequence. This addition provides steric protection against dipeptidyl peptidase-IV (DPP-IV) cleavage.
How should lyophilized Tesamorelin 10mg be stored upon arrival?
Lyophilized vials should be stored at -20°C for short-term projects or -80°C for long-term storage, protected from light and moisture in desiccated storage containers.
Does PX1 Research offer volume discounts for institutional laboratory orders?
Yes, accredited academic institutions, government labs, and commercial R&D organizations can apply for bulk procurement through our wholesale portal to access volume pricing and reserved lot allocations.
What primary research pathways are investigated using Tesamorelin?
Preclinical literature focuses on Tesamorelin's role in GHRH receptor agonism, pituitary GH pulse stimulation, downstream IGF-1 gene expression, hepatic lipid metabolism, and visceral adipose tissue regulation.
Where does PX1 Research ship Tesamorelin 10mg from?
All PX1 Research compounds are manufactured and dispatched directly from centralized, cGMP-compliant warehousing facilities in California and Arizona, with same-day shipping for orders placed before cutoff.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.